Success Story: With Our Expert Guidance, A Chinese Clinical Data Analyst/Postdoc Researcher Secured a National Interest Waiver Smoothly

 

Client’s Testimonial:

“Thanks! It has been a pleasure to work with you as well. It's quite exciting that it was approved relatively quickly without RFE and without a PP requested.”


On December 27th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Clinical Data Analyst/Postdoc Researcher in the Field of Psychiatry (Approval Notice).


General Field: Psychiatry

Position at the Time of Case Filing: Clinical Data Analyst/Postdoc Researcher

Country of Origin: China

State of Residence at the Time of Filing: Connecticut

Approval Notice Date: December 27th, 2025

Processing Time: 3 months, 12 days


Case Summary:  

We are pleased to share the success story of an I-140 EB-2 NIW (National Interest Waiver) approval for an accomplished researcher in the field of psychiatry. The client holds a Ph.D. in psychiatry and mental health and presented a research-driven petition focused on advancing neuroscience-based treatments for serious psychiatric conditions. By clearly connecting the proposed endeavor to urgent public health needs and documenting the client’s influence through objective evidence, we secured a successful NIW outcome.

The client’s proposed endeavor is to continue research on developing novel neuromodulation interventionsfor psychiatric disorders. The petition positioned this work as an area of clear substantial merit and national importance because it supports more individualized and neuroscience-driven treatment strategies that can improve patient outcomes and quality of life.

To make the case persuasive to an adjudicator, we did not rely on general statements about mental health needs. Instead, we explained how innovations in noninvasive neuromodulation can expand the toolkit for clinicians and researchers, strengthen the scientific basis for personalized interventions, and reduce the long-term burden associated with severe psychiatric disorders.

To show that the client is well positioned to advance the endeavor, we emphasized a consistent record of peer-reviewed scholarship and independent recognition. At the time of filing, the client had authored 22 peer-reviewed journal articles, including 7 first-authored works, and 1 first-authored preprint. The client’s published body of work had received 274 citations.

We did not present these metrics as automatically sufficient. Instead, we explained how an adjudicator could reasonably interpret the citation history as third-party confirmation that other researchers are actively relying on the client’s methods and findings. We also provided context showing that multiple papers performed at notably high citation levels compared to others in the same field and year of publication, which helps translate raw citation counts into clearer evidence of influence.

The petition further documented that the client had completed at least 7 peer reviews. We framed this as additional recognition because peer review invitations typically reflect confidence from journals that the reviewer has the expertise to evaluate novelty, rigor, and technical validity.

The petition also described the client’s current employment as a postdoctoral research fellow and clinical data analyst in a U.S.-based neuropsychiatry research setting. This supported the narrative that the client’s ongoing role aligns with the proposed endeavor and that the client is actively positioned to continue advancing this work in the United States.

USCIS approved the NIW petition, reflecting a well-supported presentation of the endeavor’s substantial merit and national importance, the client’s strong positioning to advance the work through a documented research record, and the overall benefit of enabling the client to continue contributing without the constraints of the labor certification process. We are proud to have guided this client to approval and look forward to the client’s continued contributions to advancing neuromodulation-based approaches that improve psychiatric care and patient quality of life in the United States.